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The ﬁrst joint meeting of the Italian and German Purine
Clubs took place in Chieti (Italy) between September
18Y20 of this year. The scientiﬁc program was collected
by the Boards of the two National Chapters headed by
F. Caciagli and P. Illes, respectively. The local organiza-
tion was most efﬁciently managed by F. Caciagli and his
team at the Campus of the University of Chieti. The
technical facilities of the Center of Excellence in Chieti
were of very high standard including the possibility of a
direct transmission of the congress events via the local
television network. The small university town of Chieti
was an ideal place for a congress; it is located at an easy
reach from the seaside resort Pescara, in a picturesque
environment of the nearby mountains of the Abbruzzo. All
of us enjoyed the warm hospitality of our hosts, the nice
scenery, the tasty food and the excellent wines served
during the social dinner.
In accordance with the attractive surrounding of this
meeting, we had a most busy program including three
state-of-the-art lectures delivered by G. Burnstock (Lon-
don, UK), G. Schmalzing (Aachen, Germany) and M.P.
Abbracchio (Milan, Italy). G. Burnstock gave a fascinating,
personal account on his discovery of ATP as a co-
transmitter in the vegetative nervous system and the
subsequent identiﬁcation and classiﬁcation of nucleotide
receptors as well as their signal transduction mechanisms
and the functional consequences of their activation [1]. It is
hard to understand nowadays the vigorous resistance of the
scientiﬁc community to approve the idea of purinergic
signalling. However, as a born ﬁghter, G. Burnstock ﬁnally
accomplished to get his convictions accepted, especially
after a wide range of P2X and P2Y receptors had been
cloned during the ﬁrst half of the last decade. We have
been deeply impressed by his last slide, where his past and
present co-workers from all over the world were enumer-
ated resulting in a never ending list of names.
G. Schmalzing spoke about the molecular mechanisms
of P2X receptor assembly and function [2]. His observa-
tion that both homomeric and heteromeric P2X receptors
have a trimeric architecture, contrast with the pentameric
(cys-loop receptors) and tetrameric (glutamate receceptors)
structure of other classes of ligand-gated ion channels. By
the circular architecture of P2X subunits around a central
axis perpendicular to the plasma membrane, each subunit
is able to contribute one or several transmembrane do-
mains to allow for the formation of the cation conduct-
ing pore. Co-immunoprecipitation experiments show that
the second transmembrane domain of each subunit car-
ries a critical determinant of a speciﬁc subunitYsubunit
interaction.
M.P. Abbracchio gave an account on the pathophysio-
logical roles of P2 receptors in glial cells [3]. Upon
mechanical stimulation or activation by other transmitters,
astrocytes release ATP and respond to ATP with a
propagating wave of intracellular calcium increases, allow-
ing homotypic astrocyte-to-astrocyte communication, as
well as a heterotropic signalling which also involves
neurons, oligodendrocytes and microglia. Astrocytic P2
receptors mediate reactive astrogliosis, a long-term reaction
which may contribute to neuroinﬂammation and neuronal
death in neurodegenerative diseases. Hence, astrocytes are
not only passive supporting elements of the CNS but also
carry on an intensive dialogue with neighbouring neurons
via e.g., purinergic signalling molecules.
In addition to the main lectures, about 40 oral commu-
nications were delivered and approximately the same
number of posters were presented by the participants. The
time reserved for each lecture and poster was amply
sufﬁcient to accommodate an intense discussion on various
items of interest. In the following, we summarize a few
Fhighlights,_ of course biased by our personal research
interests and apologize for not mentioning equally impor-
tant contributions because of lack of space or expertise.
F. Di Virgilio and co-workers (Ferrara) found that P2X7
receptors are able to modulate mitochondrial function [4].
Accordingly, sustained stimulation of P2X7 receptors
causes a drop of the resting mitochondrial potential, a
large increase in basal mitochondrial Ca
2+ concentration,
and probably as a consequence mitochondrial fragmenta-
tion and cell death. I. von Ku ¨gelgen and co-workers (Bonn)
investigated the structural determinants of the function of
P2Y1 and P2Y12 receptors. They identiﬁed two disulﬁde
bridges of which already one was sufﬁcient for receptor
function. G. Cristalli and co-workers (Camerino) synthe-
sized new analogues of adenosine, exhibiting high potency
and selectivity for the A3 adenosine receptor in binding
studies. Docking analyses of the compounds in a model of
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binding data. C.E. Mu ¨ller an co-workers (Bonn) presented
compelling evidence for the existence of an adenine (P0)
receptor, which appears to be unique as it shows very
narrow structureYactivity relationships and only accepts
minor modiﬁcations of the adenine structure. Antagonists
for this adenine receptor are not available. G. Reiser and
co-workers (Magdeburg) stably expressed P2Y1 and P2Y2
receptors with a green ﬂuorescent protein tag on their
C-terminus in HEK293 cells. Then, they conﬁrmed the
ability of diadenosine polyphosphates (ApnA; n =2 Y7) to
promote both P2Y1 and P2Y2 receptor endocytosis and to
increase arachidonic acid release. They concluded that
these compounds may regulate physiological processes via
P2Y receptor activation. P. Illes and co-workers (Leipzig)
suggested that nucleotides including ATP itself have a dual
effect both at native and recombinant P2X3 receptors. At
low concentrations ecto-protein kinase C may transfer the
terminal phosphate groups of nucleotides onto consensus
phosphorylation sites of the receptors and thereby increase
their sensitivity towards higher agonistic concentrations of
the same nucleotides.
H. Zimmermann and co-workers (Frankfurt) studied the
properties of astrocyte-like progenitor cells obtained from
the subventricular zone of the lateral ventricle. They
proved in this cell type that the signalling pathways via
extracellular nucleotides and nucleotide receptors play a
role in the control of neurogenesis. F. Caciagli and co-
workers (Chieti) suggested that brain cholesterol may have
an essential role in CNS function such as synapse
promotion [5]. They showed in addition that guanosine,
which is released both from astrocytes and neurons, and
exerts neuroprotective effects probably by stimulating the
release of various trophic factors, also increased cholester-
ol efﬂux from these cell-types. C. Martini and co-workers
(Pisa) examined in a model of rat focal cerebral ischemia
(Fmedial cerebral artery occlusion_; MCAO) the neuro-
protective effect of adenosine A2A receptors [6]. They
demonstrated that MCAO modulated the expression of
striatal A2A receptors and G protein pool availability,
suggesting that this receptor is a promising target for
neuroprotective strategies to prevent ischemic brain dam-
age. P.A. Borea and co-workers (Ferrara) found that under
hypoxic conditions adenosine up-regulates the expression
of hypoxia-inducible factor-1 (HIF-1) [7]. This effect was
mediated by A3 receptors, since it was inhibited by the
respective small interfering RNA. H. Schlu ¨ter and co-
workers (Berlin) gave an overview on dinucleotides which
were demonstrated to be released from secretory granules
of the human adrenal gland, platelets, endothelial cells and
heart tissue, yielding physiologically relevant concentra-
tions in human plasma. In vascular beds the action of the
dinucleotides was dependent on the expression proﬁle of
the purinergic receptors on the surface of endothelial cells
and vascular smooth muscle cells. M.P. Rathbone and co-
workers (Hamilton, Canada) stated that the extracellular
concentration of non-adenine-based purines such as gua-
nosine is as high or even higher than that of their adenine-
based counterpart, adenosine. They found that guanosine
protects agains apoptosis caused by a number of stimuli in
several cell-types including astrocytoma and neuroblasto-
ma cells. Further, they conﬁrmed the neuroprotective effect
of guanosine in various in vivo CNS injury models.
There was a separate poster session organized, where the
participants could carry on lively discussions on an
impressive amount of presentations. Based on suggestions
made by a committee, poster prizes were awarded to
P. Pellegatti, S. Merighi (both Ferrara), A. El-Tayeb
(Bonn), and H. Franke (Leipzig). The prizes consisted of
a diploma and a certain amount of money donated in part
by the publishing house Springer, being in charge of our
newly established journal FPurinergic Signalling._ It is
noteworthy that the Associate Editors of FPurinergic
Signalling_ have met during the congress and on suggestion
of the Editor-in-Chief, G. Burnstock, decided to urge the
participants to submit papers on their presentations.
In a separate session, the possibility of an application for
the establishment of a Research Training Network of the
European Community (EC) entitled BPathophysiology of
purinergic signalling systems[ was intensively discussed.
M.P. Abbracchio was assigned as a general coordinator of
this concerted action. Finally, P. Illes extended his warm
invitation to all participants to take part at the Second Joint
ItalianYGerman Purine Club Meeting to be organized in the
autumn of 2007 in Leipzig, Germany. He admitted that it
will be difﬁcult to cope with the high social and scientiﬁc
standards set by the present meeting, but promised that the
German organizers will do their utmost.
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